soul trial oral semaglutide cardiovascular outcomes soul trial results Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes Oral Semaglutide Cuts Cardiovascular Risk

From a systems biology and target-organ damage perspective, these findings provide a strong rationale for combination therapy

These neurotransmitters regulate everything from mood and sleep to appetite and, critically, the nausea response

Health conditions play a big role when picking a weight loss method

As an alternative to phentermine, the combination of phentermine and topiramate, the active ingredients in Qsymia, may be a suitable option

Stool softeners like docusate sodium are considered safe alongside semaglutide and can be started preventatively

If they are found to have an ischemic optic neuropathy, the decision to stop or halt treatment for diabetic management should be made on a case-by-case basis